EWA
TYRA icon

EverSource Wealth Advisors’s Tyra Biosciences TYRA Stock Holding History

EverSource Wealth Advisors’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.9K Buy
128
+86
+205% +$2.78K ﹤0.01% 3278
2025
Q4 		$1.1K Sell
42
-2
-5% -$37 ﹤0.01% 3682
2025
Q3 		$616 Buy
44
+4
+10% +$46 ﹤0.01% 3897
2025
Q2 		$383 Buy
40
+31
+344% +$295 ﹤0.01% 3957
2025
Q1 		$84 Buy
+9
New +$116 ﹤0.01% 3852

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $151M AUM 296.21% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

EverSource Wealth Advisors's TYRA Position: Q1 2026 in Review

EverSource Wealth Advisors increased its Tyra Biosciences (TYRA) stake by 205% in Q1 2026, buying an estimated $2.78K and bringing the position to 128 shares worth $4.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3278.

EverSource Wealth Advisors first reported a position in TYRA in Q1 2025 and has held it in 5 quarters since. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • EverSource Wealth Advisors held 128 shares of Tyra Biosciences worth $4.9K as of Q1 2026.
  • EverSource Wealth Advisors bought 86 Tyra Biosciences shares in Q1 2026, an estimated $2.78K.
  • Tyra Biosciences made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q1 2026, its #3278 holding.
  • EverSource Wealth Advisors first reported a position in Tyra Biosciences in Q1 2025 and has held it in 5 quarters since.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on EverSource Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.